"Biotech Mesoblast had its broker Bell Potter launch a $97.7 million equity raising on Friday morning to fund trials.The offer was split into a $36.6 million placement and a $61.1 million rights issue on a one-for-four basis. The 30¢ a share offer price was pegged at a 25.9 per cent discount to Mesoblast’s last close. It represented a 20 per cent discount to the TERP.:
"Biotech Mesoblast had its broker Bell Potter launch a $97.7...
-
- There are more pages in this discussion • 637 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.015(1.49%) |
Mkt cap ! $1.164B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | 94.0¢ | $11.76M | 11.90M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 206912 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 37637 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |